Identification of a Novel Tumor Inflammation Signature for Risk Stratification, Prognosis Prediction, and Immune Status in Colorectal Cancer

<div>Construction of a prognostic TIS model. (a) The correlation network of candidate genes. (b) LASSO coefficient expression profiles of 14 candidate genes. (c) The optimal values of the penalty parameter were evaluated by the tenfold cross-validation. (d, e) The scatter plot of risk score and survival status of prognostic TIS in CRC. (f) Kaplan-Meier curves of CRC patients’ overall survival between the high- or low-risk group. (g) The ROC analyses for 1-year, 2-year, and 3-year survival prediction of TIS.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Identification of a Novel Tumor Inflammation Signature for Risk Stratification, Prognosis Prediction, and Immune Status in Colorectal Cancer 

Figure 2 | Identification of a Novel Tumor Inflammation Signature for Risk Stratification, Prognosis Prediction, and Immune Status in Colorectal Cancer 